Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Jul;50(7):1421–1428. doi: 10.1172/JCI106625

The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia

Y M Wang 1,2, J H Patterson 1,2, J Van Eys 1,2
PMCID: PMC292080  PMID: 4397414

Abstract

NADP-linked xylitol dehydrogenase has been found to be present in human red blood cells. This enzyme activity is normal in most glucose-6-phosphate dehydrogenase (G6PD)-deficient red cells. Xylitol was explored as a potential agent for treatment of hemolysis in patients with G6PD-deficiency. Intracellular GSH (glutathione, reduced) was first converted to its oxidized form by incubation of the erythrocytes with acetylphenylhydrazine or by pretreatment with methyl phenyldiazenecarboxylate. The addition of 0.15 M xylitol was shown to be more effective than 0.15 M glucose in maintaining the levels of GSH in G6PD-deficient red cells during such oxidative challenge. Rabbit erythrocytes contain less activity of G6PD and glutathione reductase compared with the normal human adult values, but have an active xylitol dehydrogenase. The rabbit erythrocyte is sensitive to acetylphenylhydrazine and primaquine phosphate. In both in vivo and in vitro experiments, xylitol was found to partially prevent acetylphenylhydrazine induced acute hemolysis of the rabbit red cell and GSH content was found to be preserved. The intravenous injection of xylitol (0.5 g/kg body weight per 6 hr) for 6 days, seemed to be nontoxic to the animal. The results suggest that xylitol should be further investigated as an agent for the treatment of G6PD-deficient patients during acute hemolytic episodes.

Full text

PDF
1421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asakura T., Adachi K., Minagami S., Yoshikawa H. Non-glycolytic sugar metabolism in human erythrocytes. I. Xylitol metabolism. J Biochem. 1967 Aug;62(2):184–193. doi: 10.1093/oxfordjournals.jbchem.a128647. [DOI] [PubMed] [Google Scholar]
  2. Asakura T., Adachi K., Minakami S., Yoshikawa H., Nakao M. Xylit als Substrat für Methämoglobinreduktion in roten Blutkörperchen. Z Gesamte Exp Med. 1968;145(3):266–269. [PubMed] [Google Scholar]
  3. BAESSLER K. H., REIMOLD W. V. LACTATBILDUNG AUS ZUCKERN UND ZUCKERALKOHOLEN IN ERYTHROCYTEN. Klin Wochenschr. 1965 Feb 1;43:169–171. doi: 10.1007/BF01484510. [DOI] [PubMed] [Google Scholar]
  4. BAILEY J. M. A microcolorimetric method for the determination of sorbitol, mannitol, and glycerol in biologic fluids. J Lab Clin Med. 1959 Jul;54(1):158–162. [PubMed] [Google Scholar]
  5. BASSLER K. H., DREISS G. [Antiketogenic effect of xylitol in alloxan-diabetic rats]. Klin Wochenschr. 1963 Jun 15;41:593–595. doi: 10.1007/BF01487412. [DOI] [PubMed] [Google Scholar]
  6. BASSLER K. H., DREISS G. [Antiketogenic effect of xylitol in alloxan-diabetic rats]. Klin Wochenschr. 1963 Jun 15;41:593–595. doi: 10.1007/BF01487412. [DOI] [PubMed] [Google Scholar]
  7. BEUTLER E., DURON O., KELLY B. M. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963 May;61:882–888. [PubMed] [Google Scholar]
  8. BEUTLER E. The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity. J Lab Clin Med. 1957 Jan;49(1):84–95. [PubMed] [Google Scholar]
  9. BRAFIELD A. J., REEF I. Atypical congenital haemolytic anaemia. Arch Dis Child. 1957 Apr;32(162):93–98. doi: 10.1136/adc.32.162.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. CONRAD M. E., WEINTRAUB L. R., MERRILL B., CROSBY W. H. THE EFFECT OF ACETYLPHENYLHYDRAZINE UPON EPITHELIAL TURNOVER IN THE SMALL INTESTINE. Am J Dig Dis. 1965 Jan;10:43–46. doi: 10.1007/BF02235074. [DOI] [PubMed] [Google Scholar]
  11. Chan T. K., Todd D., Wong C. C. Tissue enzyme levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency. J Lab Clin Med. 1965 Dec;66(6):937–942. [PubMed] [Google Scholar]
  12. DISCHE Z., BORENFREUND E. A new spectrophotometric method for the detection and determination of keto sugars and trioses. J Biol Chem. 1951 Oct;192(2):583–587. [PubMed] [Google Scholar]
  13. Donahoe J. F., Powers R. J. Biochemical abnormalities with xylitol. N Engl J Med. 1970 Mar 19;282(12):690–691. [PubMed] [Google Scholar]
  14. Förster H., Meyer E., Ziege M. Erhöhung von Serumharsäure und Serumbilirubin nach hochdosierten Infusionen von Sorbit, Xylit und Fructose. Klin Wochenschr. 1970 Jul 15;48(14):878–879. doi: 10.1007/BF01583911. [DOI] [PubMed] [Google Scholar]
  15. GARTLER S. M., GANDINI E., CEPPELLINI R. Glucose-6-phosphate dehydrogenase deficient mutant in human cell culture. Nature. 1962 Feb 10;193:602–603. doi: 10.1038/193602a0. [DOI] [PubMed] [Google Scholar]
  16. GOOD R. A., KRIVIT W., MARVIN J. F., READ R., SMITH R. T. Congenital nonspherocytic hemolytic anemia; two nonfamilial cases with red cell survival studies. J Pediatr. 1956 Sep;49(3):245–255. doi: 10.1016/s0022-3476(56)80180-7. [DOI] [PubMed] [Google Scholar]
  17. Goto Y., Anzai M., Chiba M., Ohneda A., Kawashima S. Clinical effects of xylitol on carbohydrate and lipid metabolism in diabetes. Lancet. 1965 Nov 6;2(7419):918–921. doi: 10.1016/s0140-6736(65)92900-4. [DOI] [PubMed] [Google Scholar]
  18. Hirata Y., Fujisawa M., Sato H., Asano T., Katsuki S. Blood glucose and plasma insulin responses to xylitol administrated intravenously in dogs. Biochem Biophys Res Commun. 1966 Aug 12;24(3):471–475. doi: 10.1016/0006-291x(66)90185-9. [DOI] [PubMed] [Google Scholar]
  19. Hollmann S., Laumann G. Uber Vorkommen und Aktivität der Xylit:NADP-Oxydoreduktase (L-Sylulose-bildend) in Wirbeltieren. Hoppe Seylers Z Physiol Chem. 1967 Aug;348(8):1073–1076. [PubMed] [Google Scholar]
  20. Kosower N. S., Song K. R., Kosower E. M. Glutathione. I. The methyl phenyldiazenecarboxylate (azoester) procedure for intracellular oxidation. Biochim Biophys Acta. 1969 Oct 7;192(1):1–7. doi: 10.1016/0304-4165(69)90002-6. [DOI] [PubMed] [Google Scholar]
  21. Kosower N. S., Vanderhoff G. A., London I. M. The regeneration of reduced glutathione in normal and glucose-6-phosphate dehydrogenase deficient human red blood cells. Blood. 1967 Mar;29(3):313–319. [PubMed] [Google Scholar]
  22. Lang K., Frey R., Halmágyi M. Intra- und postoperative Infusionstherapie mit xylithaltigen Lösungen. Munch Med Wochenschr. 1966 Oct 28;108(43):2163–2165. [PubMed] [Google Scholar]
  23. Marshak M. S., Savoshchenko I. S., Gamerova V. M. Pishchevoe i lechebno-diagnosticheskoe primenenie ksilita. Sov Med. 1968 Feb;31(2):123–127. [PubMed] [Google Scholar]
  24. Müller F., Strack E., Kuhfahl E., Dettmer D. Der Stoffwechsel von Xylit bei normalen und alloxandiabetischen Kaninchen. Z Gesamte Exp Med. 1967;142(4):338–350. [PubMed] [Google Scholar]
  25. NELSON M. G. Atypical congenital haemolytic anaemia. Arch Dis Child. 1954 Oct;29(147):457–459. doi: 10.1136/adc.29.147.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Paschmi S., Opitz K. Die Beeinflussung der Insulinhypoglylämie durch Xylit. Z Gesamte Exp Med. 1968;148(1):22–27. [PubMed] [Google Scholar]
  27. RAMOT B., FISHER S., SZEINBERG A., ADAM A., SHEBA C., GAFNI D. A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency. II. Investigation of leukocyte enzymes. J Clin Invest. 1959 Dec;38:2234–2237. doi: 10.1172/JCI104004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. RAMOT B., SZEINBERG A., ADAM A., SHEBA C., GAFNI D. A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency: investigation of platelet enzymes. J Clin Invest. 1959 Sep;38:1659–1661. doi: 10.1172/JCI103943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Srivastava S. K., Beutler E. The transport of oxidized glutathione from human erythrocytes. J Biol Chem. 1969 Jan 10;244(1):9–16. [PubMed] [Google Scholar]
  30. TOUSTER O. Essential pentosuria and the glucuronate-xylulose pathway. Fed Proc. 1960 Dec;19:977–983. [PubMed] [Google Scholar]
  31. Thomas D. W., Edwards J. B., Edwards R. G. Examination of xylitol. N Engl J Med. 1970 Aug 20;283(8):437–437. doi: 10.1056/NEJM197008202830821. [DOI] [PubMed] [Google Scholar]
  32. Toussaint W., Roggenkamp K., Bässler K. H. Behandlung der Ketonämie im Kindesalter mit Xylit. Z Kinderheilkd. 1967;98(2):146–154. [PubMed] [Google Scholar]
  33. Valentine W. N. The hereditary hemolytic anemias: recent concepts and developments. South Med J. 1966 Mar;59(3):262–267. doi: 10.1097/00007611-196603000-00003. [DOI] [PubMed] [Google Scholar]
  34. Wang Y. M., Van Eys J. The enzymatic defect in essential pentosuria. N Engl J Med. 1970 Apr 16;282(16):892–896. doi: 10.1056/NEJM197004162821604. [DOI] [PubMed] [Google Scholar]
  35. ZINKHAM W. H., LENHARD R. E., Jr, CHILDS B. A deficiency of glucose-6-phosphate dehydrogenase activity in erythrocytes from patients with favism. Bull Johns Hopkins Hosp. 1958 Apr;102(4):169–175. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES